For incidence, with the NOD/SCID/IL2Rγ−/− (NSG) mouse line that is more receptive to xenograft formation, CD34+CD38+ AML cells were also able to initiate tumors [154]. This evidence concerns the gene CD34 and acute myeloid leukemia.